Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer
- 15 January 2009
- journal article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 48 (7), 642-647
- https://doi.org/10.1002/mc.20510
Abstract
There is a growing body of evidence that disturbed circadian clock gene expression is associated with tumor development and tumor progression. Based on our initial experiments demonstrating decreased period 1 (Per1) expression in colon cancer, we evaluated clock gene and estrogen receptor (ER) alpha/beta expression in colon cancer cells of primary colorectal tumors and adjacent normal colon mucosa (NM) by real‐time RT‐PCR. Analysis of gene expression in G2 and G3 colorectal tumors revealed a decrease of Per1 mRNA compared with paired NM (G2: 0.52‐fold; P = n.s. and G3: 0.48‐fold; P = 0.03). A significant gender specific difference of Per1 expression was observed in G2 tumors as compared with NM (female: 0.38‐fold; P = 0.004 vs. male: 0.73‐fold; P = n.s.). Expression of CLOCK was significantly elevated in G2 tumors of male patients (1.63‐fold, P = 0.01). The expression of ER‐beta was significantly decreased in G2 and G3 tumors (G2: 0.32‐fold; P = 0.003 and 0.27; P = 0.001). No significant gender specific differences of ER‐beta reduction in tumors were observed. A significant correlation between the decrease of Per1 and ER‐beta in colorectal tumors (r = 0.61; P < 0.001) was found. No changes in gene expression were detected for ER‐alpha and Per2. Our data demonstrate a correlated decrease of Per1 and ER‐beta in colorectal tumors, mediated probably by epigenetic mechanisms. The observed gender differences in the expression of CLOCK and Per1 in G2 tumors might suggest a gender‐specific, distinctive role of the cellular clock in colorectal tumorigenesis.Keywords
This publication has 33 references indexed in Scilit:
- Estrogen and its receptors in cancerMedicinal Research Reviews, 2008
- Estrogen receptor β deficiency enhances small intestinal tumorigenesis in ApcMin/+ miceInternational Journal of Cancer, 2008
- Oestrogen and the colon: potential mechanisms for cancer preventionThe Lancet Oncology, 2008
- Expression Levels of Estrogen Receptor β Are Modulated by Components of the Molecular ClockMolecular and Cellular Biology, 2008
- 17β-Estradiol induces ERβ up-regulation via p38/MAPK activation in colon cancer cellsBiochemical and Biophysical Research Communications, 2007
- Reflections on the Discovery and Significance of Estrogen Receptor βEndocrine Reviews, 2005
- Loss of ERβ expression as a common step in estrogen-dependent tumor progressionEndocrine-Related Cancer, 2004
- Expression of estrogen receptor ® in human colorectal cancerWorld Journal of Gastroenterology, 2004
- Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiationEuropean Journal Of Cancer, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJama-Journal Of The American Medical Association, 2002